Matthew Dansey

Matthew Dansey is an experienced business development professional currently serving as the Director of Business Development at Crinetics Pharmaceuticals since March 2023. Previously, Matthew held roles in Corporate Development at Arena Pharmaceuticals, Inc. from April 2019 to March 2023, and worked as a Business Development Consultant while self-employed in early 2019. Matthew's extensive experience includes a position as Business Development Manager at AmpliPhi Biosciences from May 2015 to January 2019, where responsibilities included executing business development strategies, managing external intellectual property counsel, and overseeing mergers and acquisitions. Earlier roles included an Analyst position at Harvey & Company and internships in Hematology/Oncology Research at Amgen. Matthew holds a Juris Doctorate in Intellectual Property and Corporate Law from the University of San Diego School of Law and a Bachelor of Science in Neuroscience with a minor in Political Philosophy from the University of Michigan.